You are here

Succor Combat Foam for Treatment of Dermal Injuries Caused by Sulfur Mustard

Award Information
Agency: Department of Defense
Branch: Office for Chemical and Biological Defense
Contract: W911SR-22-P-0004
Agency Tracking Number: C212-005-0004
Amount: $167,499.96
Phase: Phase I
Program: SBIR
Solicitation Topic Code: CBD212-005
Solicitation Number: 21.2
Solicitation Year: 2021
Award Year: 2022
Award Start Date (Proposal Award Date): 2022-02-22
Award End Date (Contract End Date): 2022-08-22
Small Business Information
392 East Beach Avenue
Inglewood, CA 90302-1111
United States
DUNS: 078821727
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 Ross Donaldson
 (310) 500-6064
Business Contact
 Diane Goldenberg
Phone: (714) 206-8695
Research Institution

The Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical (JPM CBRN Medical) seeks to develop dermal dressing technologies that provide multiple advantages over current wound dressings for treating dermal injuries caused by sulfur mustard. Critical Innovations, Battelle's Biomedical Research Center, and NDA Partners, with consultants Captain David Tanen, MD, FAAEM, FACMT (USN, Ret.) and Dr. David Greenhalgh, MD, FACS, have formed a team of medical device experts to address this important medical need. During this Phase I project, our objectives will be to further advance the innovative Succor product. This will include: 1) On-boarding program requirements, goals, and schedule; 2) Gathering existing data on the efficacy of Succor for treatment of similar dermal injuries; 3) Formalizing a regulatory plan to obtain an FDA indication for HD dermal injury; 4) Preparing a draft research plan for subsequent small-animal studies; and, 6) Maintaining all regulatory compliance requirements while preparing for upcoming regulatory and transition hurdles (TRL 6).

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government